Blogs about: Biovex
Featured Blog
What does the $ 1 Bn deal by Amgen on oncolytic viruses manifest?
This week Amgen announced to acquire BioVex, a biotech with its lead product OncoVEX oncolytic virus in phase III for advanced melanoma, for $ 1Bn. “It’s a call option on a late-stage, pot… more →
Developing oncolytic virus therapies
What does the $ 1 Bn deal by Amgen on oncolytic viruses manifest?
— 1 comment
wrote 2 years ago: This week Amgen announced to acquire BioVex, a biotech with its lead product OncoVEX oncolytic virus … more →
Amgen buys Biovex for up to $1 billion
wrote 2 years ago: Amgen has announced that it has agreed to buy Biovex, a maker of experimental cancer drugs for $425 … more →
"Maturing data in 2011 will get us focused on the oncolytic virus industry."
wrote 2 years ago: This is what I repeatedly heard from the top pharma licensing and business development executives in … more →
Will BioVex cure melanoma with its OncoVEX oncolytic virus?
— 3 comments
wrote 2 years ago: Advanced melanoma for sure is a challenging enough target: there are no new FDA-approved medications … more →
Will 2010 be the year of oncolytic viruses?
wrote 3 years ago: I believe it can be. A snapshot conversation at BIO Europe Spring 2010 with in-licensing executives … more →
Oncolytic virus pulse at BioEurope Spring 2010
— 1 comment
wrote 3 years ago: Two inches of snow in Barcelona made BioEurope Spring 2010 a memorable event for many participants. … more →
Derm News Thursday, November 12
wrote 3 years ago: Broad and Informative Healthy Skin Doesn’t Have to Put a Wrinkle in Your Budget -NY1 Dermatolo … more →
